CFO Lin Peter Kuan‑How Boosts Stake in Apollomics Amid Mixed Buy‑Sell Cycle, Reinforcing Management Confidence in Oncology Growth Flash 06/15/2026
Apollomics CFO Lin Peter Kuan‑How buys 10k shares, sells 3,588, and vests RSUs—boosting his stake and signaling management confidence amid the stock’s volatility.
3 minutes to read

